Compounds > pentetic acid

pentetic acid and actinium

pentetic acid has been researched along with actinium in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor, DM1
Apostolidis, C; Bos, E; Doornmalen, AV; Geerlings, MW; Kaspersen, FM; Molinet, R1
Bochsler, PN; Boll, RA; Brechbiel, MW; Davis, IA; Deal, KA; Glowienka, KA; Kennel, SJ; Mirzadeh, S; Stabin, M1
Blechert, B; Bruchertseifer, F; Essler, M; Gärtner, FC; Morgenstern, A; Neff, F; Seidl, C; Senekowitsch-Schmidtke, R1

Other Studies

4 other study(ies) available for pentetic acid and actinium

ArticleYear
The effects of desferrioxamine on the retention of actinide elements in the rat.
    Health physics, 1967, Volume: 13, Issue:2

    Topics: Actinium; Americium; Animals; Curium; Deferoxamine; Femur; Kidney; Liver; Male; Pentetic Acid; Plutonium; Radiation Injuries, Experimental; Rats; Spleen; Thorium

1967
Cytotoxicity of 213Bi- and 225Ac-immunoconjugates.
    Nuclear medicine communications, 1995, Volume: 16, Issue:6

    Topics: Actinium; Animals; Antibody Specificity; Bismuth; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Dose-Response Relationship, Radiation; Humans; Immunoconjugates; Immunoglobulin G; Kinetics; Mice; Pentetic Acid; Radioisotopes; Tumor Cells, Cultured

1995
Comparison of 225actinium chelates: tissue distribution and radiotoxicity.
    Nuclear medicine and biology, 1999, Volume: 26, Issue:5

    Topics: Actinium; Animals; Chelating Agents; Dose-Response Relationship, Radiation; Female; Isothiocyanates; Mice; Mice, Inbred BALB C; Pentetic Acid; Structure-Activity Relationship; Tissue Distribution

1999
Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:4

    Topics: Actinium; Animals; Bismuth; Cell Line, Tumor; Disease Models, Animal; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Kidney; Mice; Organometallic Compounds; Pentetic Acid; Peptides; Peritoneal Neoplasms; Radioisotopes; Treatment Outcome; Xenograft Model Antitumor Assays

2012